Human peripheral blood monocytes express plasma membrane receptors for fibronectin that is bound to substrates such as denatured collagen, gelatin, and fbrin (1). After attachment to surfaces containing fibronectin, monocytes express physiological characteristics usually attributed to inflammatory macrophages (2). Immune phagocytic activity is enhanced, as indicated by increased uptake of particles opsonized by IgG and C3 (1) and the engagement of C3 receptors in phagocytosis (3). In addition, secretion of neutral proteases such as plasminogen activator and elastase after a phagocytic stimulus is enhanced (4). Fibronectin receptors thus appear to be involved in the differentiation of blood monocytes into more active, inflammatory cells. In vivo, at a site of injury, these cells would be more effective in the clearance of debris and microorganisms in preparation for tissue reconstruction.We have previously described the basic features of fibronectin receptors of human monocytes (1). These receptors are present on most, if not all, human peripheral blood monocytes (5) and on peritoneal macrophages (6, 7), alveolar macrophages (8), and macrophage cell lines (9). Receptors can be detected by their ability to mediate the attachment of monocytes to fibronectin-containing surfaces or by the attachment of fibronectin-coated particles to monocytes (1). The interaction of receptor and ligand requires Mg ++ and is reversed by chelation of this divalent cation with EDTA. Both monomeric (190-235 kD) and dimeric (450 kD) forms of plasma fibronectin promote monocyte attacfiment to gelatin surfaces. Soluble fibronectin, however, interacts poorly with the receptor. We have also found that trypsinization abolishes the ability of monocytes to bind to fibronectin-gelatin surfaces, suggesting that a protein-containing structure on the cell surface is involved in receptor activity.In the present paper we describe a molecule on the surface of human peripheral blood monocytes that appears to be a plasma membrane receptor for fibronectin. This protein has been identified by using a monoclonal antibody, A6F 10, that prevents the interaction between monocytes and substrate-bound fibronectin. Thus, at least functionally, the antibody appears to recognize the plasma membrane receptor for fibronectin. We define the properties of this monoclonal